PJT Partners delivered its weakest quarter of 2026. Adjusted EPS of $1.41 missed the $1.44 consensus by 2.1%, and revenue of $385.12 million fell 6.1% short of the $410.0 million estimate. The bigger story is the reversal in growth. Earnings fell 23.8% year over year and revenue declined 13.9%, compared with revenue gains of 20% in the second quarter and 29% in the first. Management presented the quarter as a completion-timing air pocket rather than a break in the franchise, and the nine-month record results support that view. The central tension is that PJT says its top-of-funnel activity is at a record, while fewer of those deals are converting into closed transactions.

The EPS miss was smaller than the revenue miss, and the reason matters. PJT lowered its compensation accrual rate. The adjusted comp ratio fell to 66.5% from 67.5% a year ago, so compensation expense dropped 15%, slightly faster than revenue. Non-compensation expense moved the other way, rising 10% to $56.7 million and climbing to 14.7% of revenue from 11.5%. The company cited technology and market-data spending, a larger global office footprint and higher travel. The adjusted pretax margin compressed to 18.8%, down from 21.0% a year ago and 21.7% in the second quarter. GAAP diluted EPS fell 22% to $1.15. Through nine months, revenue rose 9% to a record $1.29 billion, adjusted EPS rose 11% to $4.92, and the pretax margin improved to 20.3%. The year-to-date picture is still strong, but the third quarter clearly bent the trajectory downward.

The call added texture that investors may not like. Every business line declined in the quarter, according to the call. CEO Paul Taubman described lower M&A conversion rates and said sponsor activity showed only "a little frost off the windshield." That language is notably cooler than the second-quarter call, which highlighted mandates up more than 20% and a record pre-announced pipeline. No mandate statistics were offered this time. Two sources conflict on fundraising. The release credits higher primary fundraising revenue with partially offsetting declines elsewhere. The call, however, described primary fundraising as still challenged and said PJT Park Hill declined in the quarter, while also maintaining that Park Hill remains on track for record full-year revenue. Investors should treat the private capital solutions picture as unsettled. Management stressed "years, not quarters" throughout, and the tone was more defensive than in July.

The forward catalysts are real but deferred. Management reaffirmed expectations for record full-year results and the 66.5% comp ratio, and it lowered the 2026 tax rate to 19.2% from 20.5%. It also said:

• 2026 is shaping up as the biggest partner-recruiting year in the firm's history, with the additions expected to show in partner count by early 2027.
• PJT expects to enter 2027 with a meaningfully improved announced backlog, compared with flat levels entering 2026.
• Restructuring carries a record pipeline, with a gradual shift toward in-court work and AI-related financing stress cited as a potential source of mandates.
• Large, consequential M&A could be pulled forward over the next six months ahead of the 2028 election cycle.

Against that, bears have legitimate ammunition. The 2027 tax rate is guided to roughly 25%, partly due to Section 162(m) expansion, which is a meaningful EPS headwind. Rising rates and wider credit spreads are pressuring sponsor M&A, and China remains a regulatory wild card. The balance sheet is a clear strength, with record cash and investments of $766 million, up from $535 million in the second quarter, and no funded debt. Even so, buybacks slowed to about 0.2 million shares from roughly 498,000 in the prior quarter.

The market had already been marking down expectations. Investor sentiment slipped from modestly positive (0.13) to slightly negative (-0.04), a meaningful but not dramatic shift. Shares at $153.58 as of November 2 were down 8.1% since the open following the July report and sat about 1.8% below the 200-day moving average. The stock has been volatile. It peaked at $187.57 in early September, fell to $131.37 in mid-October, and has since recovered roughly halfway through that range. The trend readings are mixed: price and AVWAP trends are negative while momentum is positive.

The bottom line is that PJT's third quarter was a genuine miss with decelerating growth, compressing margins and rising non-comp costs. A lighter comp accrual and a lower tax rate cushioned the EPS damage. Management's case rests on conversion and timing: a record funnel, a stronger 2027 backlog, aggressive recruiting and a busy restructuring pipeline. That case is credible given the nine-month record, but it now needs fourth-quarter completions to validate it, with a higher 2027 tax rate already working against the earnings outlook.